QJM Advance Access originally published online on April 3, 2008
QJM 2008 101(7):535-543; doi:10.1093/qjmed/hcn043
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
An integrated care pathway improves quality of life in Primary Biliary Cirrhosis
From the Institute of Cellular Medicine and the Regional Primary Biliary Cirrhosis, University of Newcastle and Newcastle Hospitals NHS Trust, Newcastle, UK
Address correspondence to Dr Julia Newton, Senior Lecturer and Consultant Physician, Institute of Cellular Medicine, Newcastle University, Newcastle, NE2 4HH, UK. email: Julia.newton{at}nuth.nhs.uk; julianewton{at}blueyonder.co.uk
Received 7 January 2008 and in revised form 5 March 2008
 |
Abstract |
|---|
Background: Clinical management of the chronic autoimmune liver disease, Primary Biliary Cirrhosis (PBC) involves addressing the underlying liver disease and a range of symptoms independent of liver disease severity. We have formally explored how these two perspectives of chronic disease management can be combined into a clinic consultation and impact upon quality of life (QOL) in PBC.
Aims: To develop and implement the first Integrated Care Pathway (ICP) for the management of liver disease progression and symptom management in PBC.
Methods: Process mapping of current practice by a multidisciplinary group developed a flowchart of care from which the clinical record evolved. Symptom assessment is incorporated into the PBC ICP (QOL; PBC-40, autonomic symptoms; Orthostatic Grading Scale, daytime sleepiness; Epworth Sleepiness Scale). All patients were considered who attended clinic between July 2005 and June 2006. Symptom assessment was repeated after 1 year in those participating in the initial clinic cohort.
Results: The PBC ICP was successfully introduced into our clinical environment with high levels of patient satisfaction. A total of 225 PBC patients attended over 12 months. Initial QOL assessments were in 195 (87%). Five patients died (3%). Repeat assessment 1 year later occurred in 149 subjects (149/190; 78%). All symptom domains improved after ICP implementation with significant improvements in those with moderate and severe symptoms in all PBC-40 symptom domains (P < 0.02). In those with severe fatigue (n = 38) symptom improvement was even more dramatic (P = 0.002).
Conclusion: ICP implementation delivers evidence-based care, leads to improvements in QOL coupled with high levels of patient satisfaction.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D.E.J. Jones, J.C. Gray, and J. Newton Perceived fatigue is comparable between different disease groups QJM, September 1, 2009; 102(9): 617 - 624. [Abstract] [Full Text] [PDF]
|
|